Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Vaccine Exports May Halt If Central Authority Does Not Comply With GMP Norms

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Large vaccine manufacturers in India may not be able to export their key products for long, nor can they cater to domestic demand, as the apex testing laboratory for vaccines - the Central Research Institute - has been de-recognized from doing such tests by the Drug Controller General of India.

Related Content

UsernamePublicRestriction

Register

SC069449

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel